Companies
Ford Adjusts Prices on Electric F-150 Lightning to Enhance Accessibility
Automaker Cuts Costs as it Resumes Shipments after Quality Issues Disruption Ford Motor (F) is reducing the starting prices of...
Allegations of Hacking and Boardroom Coup Shake Trump-Linked Media Company
Former SPAC CEO and Investment Firms Accuse Board Member of Data Theft and Corporate Intrigue Investment firms, led by the...
Rent the Runway Surpasses Expectations, Eyes Growth and Profitability in 2024
Innovations, Customer Retention Strategies Drive Positive Financial Performance Rent the Runway (RENT), the pioneering shared designer closet platform, exceeded revenue...
Candel Therapeutics’ CAN-2409 Receives FDA Orphan Drug Designation for Pancreatic Cancer
Milestone Achievement Enhances Development Efforts for Multimodal Biological Immunotherapy Candel Therapeutics (CADL) has achieved a significant milestone in its fight...
Rallybio Collaborates with Johnson & Johnson to Tackle Rare Disease FNAIT
Partnership Aims to Develop Therapeutic Solutions for Fetal and Neonatal Alloimmune Thrombocytopenia Rallybio Corporation (RLYB) has announced a collaboration with...
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in $4.9 Billion Deal
Acquisition Strengthens Vertex's Position in Immunotherapy and Renal Disease Treatment Vertex Pharmaceuticals (VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN)...
Delta Airlines Sees Profit Surge Amidst Strong Travel Demand
CEO Ed Bastian Forecasts Growth Despite Inflation, Prioritizes Efficiency Over Hiring Delta Airlines (DAL) reported a significant turnaround in the...
Advancing Addiction Treatment: Adial Pharmaceuticals’ AD04 Shows Promise in Clinical Study
Peer-Reviewed Article Highlights Safety and Efficacy of Low-Dose Ondansetron in Treating Alcohol Use Disorder Adial Pharmaceuticals (ADIL), a pioneer in...
The Bitcoin Halving: Insights from CEOs and its Impact on Mining Companies
Understanding the Effects on Miners, Key Players, and the Overall BTC Price The upcoming Bitcoin halving event has sparked anticipation...
Moderna’s Cancer Vaccine Shows Positive Results, Shares Surge
Early-Stage Trial Signals Potential Breakthrough in Cancer Treatment Moderna (MRNA) witnessed a significant uptick in its shares, climbing 8% to...
